| Christopher John Smith, MD | |
|
601 E Rollins St, Orlando, FL 32803-1248 | |
| (407) 200-2355 | |
| Not Available |
| Full Name | Christopher John Smith |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 12 Years |
| Location | 601 E Rollins St, Orlando, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023374014 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Orlando | Orlando, FL | Hospital |
| Adventhealth Waterman | Tavares, FL | Hospital |
| Adventhealth Daytona Beach | Daytona beach, FL | Hospital |
| Adventhealth New Smyrna Beach | New smyrna beach, FL | Hospital |
| Adventhealth Fish Memorial | Orange city, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Florida Hospital Medical Group Inc | 0042383200 | 218 |
| Florida Radiology Imaging At Lake Mary Llc | 1254311137 | 170 |
| Florida Hospital Medical Group Inc | 0042383200 | 218 |
News Archive
IRIN reports on the HIV/AIDS response in Guinea-Bissau, writing, "One year after the Global Fund to Fight AIDS, Tuberculosis and Malaria reduced funding to the Guinea-Bissau government body in charge of coordinating HIV prevention and treatment activities, health centers outside the capital are facing medicine shortages, patients are not receiving the treatment they need, and the transport of patients to treatment centers has been cut."
Sponsored by Valurise Health Solutions International, and guided/supported by the Chinese workers' mutual Insurance Association All-China Federation of Trade Unions, the China Insurance Association and the International Disease Management Alliance, the 2011 International Health Risk Management Forum, Opportunity and Challenge of Health Risk Management in the Transition Period in China is going to be held on 20th April, 2011 in the National Convention Centre in Beijing, China.
Sirnaomics, Inc. (www.sirnaomics.com) announced today that the company has licensed a polypeptide nanoparticle technology invented by Professor A. James Mixson of University of Maryland Medical School.
According to a new study the addition of an experimental immunotherapy drug to the standard regimen of care extended the lives and decreased the risk of a disease recurrence in children with high-risk neuroblastoma. This tumor most frequently originates in one of the adrenal glands, but can also develop in nerve tissues in the neck, chest, abdomen, or pelvis. It forms 12 percent of cancer-related deaths in children under the age of 15 and half of patients with this type of malignancy have the high-risk form.
› Verified 1 days ago
| Entity Name | Florida Radiology Imaging At Lake Mary Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740256494 PECOS PAC ID: 1254311137 Enrollment ID: O20040721001414 |
News Archive
IRIN reports on the HIV/AIDS response in Guinea-Bissau, writing, "One year after the Global Fund to Fight AIDS, Tuberculosis and Malaria reduced funding to the Guinea-Bissau government body in charge of coordinating HIV prevention and treatment activities, health centers outside the capital are facing medicine shortages, patients are not receiving the treatment they need, and the transport of patients to treatment centers has been cut."
Sponsored by Valurise Health Solutions International, and guided/supported by the Chinese workers' mutual Insurance Association All-China Federation of Trade Unions, the China Insurance Association and the International Disease Management Alliance, the 2011 International Health Risk Management Forum, Opportunity and Challenge of Health Risk Management in the Transition Period in China is going to be held on 20th April, 2011 in the National Convention Centre in Beijing, China.
Sirnaomics, Inc. (www.sirnaomics.com) announced today that the company has licensed a polypeptide nanoparticle technology invented by Professor A. James Mixson of University of Maryland Medical School.
According to a new study the addition of an experimental immunotherapy drug to the standard regimen of care extended the lives and decreased the risk of a disease recurrence in children with high-risk neuroblastoma. This tumor most frequently originates in one of the adrenal glands, but can also develop in nerve tissues in the neck, chest, abdomen, or pelvis. It forms 12 percent of cancer-related deaths in children under the age of 15 and half of patients with this type of malignancy have the high-risk form.
› Verified 1 days ago
| Entity Name | Florida Hospital Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073785044 PECOS PAC ID: 0042383200 Enrollment ID: O20080721000717 |
News Archive
IRIN reports on the HIV/AIDS response in Guinea-Bissau, writing, "One year after the Global Fund to Fight AIDS, Tuberculosis and Malaria reduced funding to the Guinea-Bissau government body in charge of coordinating HIV prevention and treatment activities, health centers outside the capital are facing medicine shortages, patients are not receiving the treatment they need, and the transport of patients to treatment centers has been cut."
Sponsored by Valurise Health Solutions International, and guided/supported by the Chinese workers' mutual Insurance Association All-China Federation of Trade Unions, the China Insurance Association and the International Disease Management Alliance, the 2011 International Health Risk Management Forum, Opportunity and Challenge of Health Risk Management in the Transition Period in China is going to be held on 20th April, 2011 in the National Convention Centre in Beijing, China.
Sirnaomics, Inc. (www.sirnaomics.com) announced today that the company has licensed a polypeptide nanoparticle technology invented by Professor A. James Mixson of University of Maryland Medical School.
According to a new study the addition of an experimental immunotherapy drug to the standard regimen of care extended the lives and decreased the risk of a disease recurrence in children with high-risk neuroblastoma. This tumor most frequently originates in one of the adrenal glands, but can also develop in nerve tissues in the neck, chest, abdomen, or pelvis. It forms 12 percent of cancer-related deaths in children under the age of 15 and half of patients with this type of malignancy have the high-risk form.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher John Smith, MD 601 E Rollins St, Orlando, FL 32803-1248 Ph: (407) 200-2355 | Christopher John Smith, MD 601 E Rollins St, Orlando, FL 32803-1248 Ph: (407) 200-2355 |
News Archive
IRIN reports on the HIV/AIDS response in Guinea-Bissau, writing, "One year after the Global Fund to Fight AIDS, Tuberculosis and Malaria reduced funding to the Guinea-Bissau government body in charge of coordinating HIV prevention and treatment activities, health centers outside the capital are facing medicine shortages, patients are not receiving the treatment they need, and the transport of patients to treatment centers has been cut."
Sponsored by Valurise Health Solutions International, and guided/supported by the Chinese workers' mutual Insurance Association All-China Federation of Trade Unions, the China Insurance Association and the International Disease Management Alliance, the 2011 International Health Risk Management Forum, Opportunity and Challenge of Health Risk Management in the Transition Period in China is going to be held on 20th April, 2011 in the National Convention Centre in Beijing, China.
Sirnaomics, Inc. (www.sirnaomics.com) announced today that the company has licensed a polypeptide nanoparticle technology invented by Professor A. James Mixson of University of Maryland Medical School.
According to a new study the addition of an experimental immunotherapy drug to the standard regimen of care extended the lives and decreased the risk of a disease recurrence in children with high-risk neuroblastoma. This tumor most frequently originates in one of the adrenal glands, but can also develop in nerve tissues in the neck, chest, abdomen, or pelvis. It forms 12 percent of cancer-related deaths in children under the age of 15 and half of patients with this type of malignancy have the high-risk form.
› Verified 1 days ago
Rola Altoos, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 601 E Rollins St, Orlando, FL 32803 Phone: 407-200-2355 | |
Steven D. Beesley, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 86 W Underwood St, Suite 201, 2nd Floor, Orlando, FL 32806 Phone: 321-841-5142 Fax: 407-648-3686 | |
Dr. Joseph N Foss, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 52 W Underwood St, Orlando, FL 32806 Phone: 321-842-8475 Fax: 407-849-6470 | |
Alan M Litwin, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 9037 Point Cypress Dr, Orlando, FL 32836 Phone: 813-745-7365 Fax: 813-449-8618 | |
Dr. Robert C Hudak, MD Radiology Medicare: Medicare Enrolled Practice Location: 20 W Kaley St, Orlando, FL 32806 Phone: 407-423-2581 Fax: 407-849-6470 | |
Dr. Christopher T Rush, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 601 E Rollins St, Orlando, FL 32803 Phone: 407-303-5600 Fax: 317-705-5047 | |
Dr. John Franklin Hoy, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 13800 Veterans Way, Orlando, FL 32827 Phone: 407-631-1120 |